Bio-Rad Laboratories Profit Margin

The latest profit margin for BIO.B is 39.45% as of September 2026. That compares with -28.93% in the prior-year period — up 236.4% year over year. That is above the Healthcare sector average of 9.48%. Investors often review this figure alongside Bio-Rad Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIO.B's profit margin moved from -28.93% to 39.45% — a 236.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bio-Rad Laboratories's valuation or profitability profile.

Against Healthcare companies, BIO.B currently prints 39.45% for profit margin, while the sector average sits near 9.48%. That is roughly 316.1% above the sector mean. Large gaps often invite a closer look at Bio-Rad Laboratories's growth, margins, and balance sheet.

Profit Margin shows how effectively Bio-Rad Laboratories converts resources into returns. At 39.45%, BIO.B may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -28.93% in the prior-year period — up 236.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIO.B's profit margin (39.45%), review year-over-year change from -28.93%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.